Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural

Harry Bulstrode1, Gemma C Girdler1, Tannia Gracia2

  • 1Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.

Neuron
|September 29, 2022
PubMed

Insights

Zika virus infects developing brain cells, causing microcephaly. Glioblastoma cells, however, resist infection due to microglia-mediated innate immunity, offering potential for brain cancer therapies.

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Background:

  • Zika virus (ZIKV) causes microcephaly by infecting human developing brain (HDB) progenitors.
  • Glioblastoma (GBM), an adult brain cancer, shares cellular tropism with HDB, suggesting therapeutic potential.
  • SOX2+ neural progenitors are present in both HDB and GBM tissues.

Purpose of the Study:

  • To compare ZIKV infection susceptibility in HDB and GBM primary tissue explants.
  • To investigate the role of innate immunity in ZIKV resistance in GBM.
  • To explore therapeutic strategies for ZIKV-induced microcephaly and GBM oncolysis.

Main Methods:

  • Primary tissue explants from HDB and GBM were infected with ZIKV.
  • SOX2+ GBM cell lines and HDB progenitor lines were utilized.
  • Conditioned medium from CD11b+ microglia/macrophages and type 1 interferon beta (IFNβ) were applied.
  • JAK1/2 signaling inhibition was employed to assess its effect on ZIKV infection.

Main Results:

  • HDB progenitors were uniformly vulnerable to ZIKV infection.
  • GBM tissues exhibited resistance to ZIKV, correlated with an innate immune signature.
  • GBM-derived CD11b+ microglia/macrophages conferred non-cell autonomous protection against ZIKV.
  • IFNβ, present in CD11b+-conditioned medium, induced resistance in both GBM and HDB progenitors.
  • JAK1/2 inhibition restored productive ZIKV infection in GBM progenitors.

Conclusions:

  • GBM-associated innate immunity, particularly from microglia/macrophages, protects neural progenitors from ZIKV.
  • IFNβ signaling is a key mechanism for ZIKV resistance in both developing and adult brain contexts.
  • These findings offer insights for neuroprotection strategies and enhancing oncolytic virotherapy for glioblastoma.

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...